Inventor · disambiguated record
Federico C. A. Gaeta
Also filed as: GAETA FEDERICO · GAETA FEDERICO C · GAETA FEDERICO C A
49 granted patents·10 pending applications·2,020 citations·filing 1984–2025
99Inventor score
Top patents by PatentIndex Score
59 records- 0198US6440735B1Dendritic cell vaccine containing telomerase reverse transcriptase for the treament of cancerGERON CORP·Filed 2000·Granted Aug 27, 2002·113 cites·22 claims
- 0298US5374541ACombined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharidesSCRIPPS RESEARCH INST·Filed 1993·Granted Dec 20, 1994·223 cites·11 claims
- 0397US5736142AAlteration of immune response using pan DR-binding peptidesCYTEL CORP·Filed 1994·Granted Apr 7, 1998·300 cites·56 claims
- 0495US7084141B2Inhibitors of macrophase migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2005·Granted Aug 1, 2006·27 cites·44 claims
- 0594US5770573ACS-1 peptidomimetics, compositions and methods of using the sameCYTEL CORP·Filed 1995·Granted Jun 23, 1998·168 cites·14 claims
- 0694US5559103ABivalent sialyl X saccharidesCYTEL CORP·Filed 1994·Granted Sep 24, 1996·141 cites·27 claims
- 0793US5767278ATelomerase inhibitorsGERON CORP·Filed 1995·Granted Jun 16, 1998·80 cites·22 claims
- 0893US5656638ATelomerase inhibitorsGERON CORP·Filed 1995·Granted Aug 12, 1997·97 cites·29 claims
- 0992US5863936ATelomerase inhibitorsGERON CORP·Filed 1995·Granted Jan 26, 1999·71 cites·22 claims
- 1090US7514225B2Method for screening an agent that modulates activity of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2005·Granted Apr 7, 2009·8 cites·11 claims
- 1190US5770613ATelomerase inhibitorsGERON CORP·Filed 1995·Granted Jun 23, 1998·58 cites·45 claims
- 1289US7105519B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2002·Granted Sep 12, 2006·17 cites·107 claims
- 1389US5753631AIntercellular adhesion mediatorsCYTEL CORP·Filed 1995·Granted May 19, 1998·90 cites·9 claims
- 1489US5604207ASialyl Lex analogues as inhibitors of cellular adhesionCYTEL CORP·Filed 1994·Granted Feb 18, 1997·91 cites·44 claims
- 1588US6413935B1Induction of immune response against desired determinantsEPIMMUNE INC·Filed 1997·Granted Jul 2, 2002·73 cites·52 claims
- 1688US5760062ATelomerase inhibitorsGERON CORP·Filed 1995·Granted Jun 2, 1998·56 cites·9 claims
- 1787US7585875B2Substituted pyrazolo[1,5-a]pyridine compounds and their methods of useAVIGEN INC·Filed 2007·Granted Sep 8, 2009·8 cites·9 claims
- 1887US7129236B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Oct 31, 2006·5 cites·42 claims
- 1987US5679640AImmunosuppressant peptidesCYTEL CORP·Filed 1995·Granted Oct 21, 1997·89 cites·17 claims
- 2085US5703116ATelomerase InhibitorsGERON CORP·Filed 1995·Granted Dec 30, 1997·38 cites·22 claims
- 2184US7732146B2Method for screening an agent that modulates activity of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2005·Granted Jun 8, 2010·3 cites·9 claims
- 2284US7202351B1Alteration of immune response using pan DR-binding peptidesPHARMEXA INC·Filed 2000·Granted Apr 10, 2007·20 cites·14 claims
- 2384US7192961B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Mar 20, 2007·3 cites·27 claims
- 2482US7824849B2Cellular telomerase vaccine and its use for treating cancerGERON CORP·Filed 2006·Granted Nov 2, 2010·3 cites·8 claims
- 2582US7432374B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2007·Granted Oct 7, 2008·2 cites·7 claims
- 2681US7435737B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Oct 14, 2008·2 cites·11 claims
- 2780US5811404ASialyl Lex analogues as inhibitors of cellular adhesionCYTEL CORP·Filed 1995·Granted Sep 22, 1998·68 cites·5 claims
- 2879US5821231ACS-1 peptidomimetics, compositions and methods of using sameCYTEL CORP·Filed 1995·Granted Oct 13, 1998·50 cites·25 claims
- 2978US7238809B2Process for the preparation of inhibitors of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2006·Granted Jul 3, 2007·1 cites·24 claims
- 3078US7235565B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Jun 26, 2007·1 cites·52 claims
- 3178US7230106B2Process for the preparation of inhibitors of macrophage migration inhibitory factorAVANIR PHARMACEUTICALS·Filed 2006·Granted Jun 12, 2007·1 cites·19 claims
- 3278US7202248B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Apr 10, 2007·1 cites·62 claims
- 3378US7157469B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Jan 2, 2007·1 cites·42 claims
- 3476US7402307B2Method for identifying and killing cancer cellsGERON CORP·Filed 2002·Granted Jul 22, 2008·3 cites·23 claims
- 3576US7192955B2Inhibitors of macrophage migration inhibitory factor and methods for identifying the sameAVANIR PHARMACEUTICALS·Filed 2006·Granted Mar 20, 2007·1 cites·52 claims
- 3675US5936065ACS-1 peptidomimetics, compositions and methods of using the sameCYTEL CORP·Filed 1995·Granted Aug 10, 1999·41 cites·2 claims
- 3775US5688913ACS-1 peptidomimetics, compositions and methods of using the sameCYTEL CORP·Filed 1995·Granted Nov 18, 1997·25 cites·18 claims
- 3874US11701374B18-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expressionANDREWS WILLIAM H·Filed 2011·Granted Jul 18, 2023·2 cites·4 claims
- 3970US12168019B18-hydroxy quinoline derivatives for enhancing telomerase reverse transcriptase (TERT) expressionSIERRA SCIENCES INC·Filed 2022·Granted Dec 17, 2024·0 cites·17 claims
- 4067US2025120956A1Azole Compounds for Enhancing Telomerase Reverse Transcriptase (TERT) ExpressionSIERRA SCIENCES INC·Filed 2024·Application pending·0 cites
- 4164US2010035920A1SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USEAVIGEN INC·Filed 2009·Application pending·0 cites
- 4264US2009318437A1SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USEGAETA FEDERICO C A·Filed 2009·Application pending·0 cites
- 4357US12404304B1Telomerase reverse transcriptase (TERT) expression enhancing compounds and methods for using the sameSIERRA SCIENCES LLC·Filed 2020·Granted Sep 2, 2025·0 cites·4 claims
- 4457US5015641AAntiglaucoma agentsANDREWS DAVID R·Filed 1989·Granted May 14, 1991·7 cites·9 claims
- 4555US2009221629A1Method for antagonizing MIF activityAVIGEN INC·Filed 2009·Application pending·0 cites
- 4654US7622256B2Method for selecting compounds that modulate MIF-induced expression of ICAM-1 and/or VCAM-1AVIGEN INC·Filed 2007·Granted Nov 24, 2009·0 cites·1 claims
- 4754US2005049197A1Induction of immune response against desired determinantsEPIMMUNE INC·Filed 2004·Application pending·0 cites
- 4853US4634698AAntiglaucoma agentsSCHERING CORP·Filed 1985·Granted Jan 6, 1987·10 cites·10 claims
- 4951US2009143451A1Compounds that increase telomerase reverse transcriptase (tert) expression and methods for using the sameANDREWS WILLIAM H·Filed 2008·Application pending·0 cites
- 5051US2025179122A1Telomerase Reverse Transcriptase (TERT) Expression Enhancing Compounds and Methods for Using the SameSIERRA SCIENCES LLC·Filed 2025·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Federico C. A. Gaeta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →